Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
rare diseases
RNA-based therapeutics antisense technology |
| gptkbp:formerName |
gptkb:Sarepta_Therapeutics
|
| gptkbp:foundedIn |
1980
|
| gptkbp:headquartersLocation |
gptkb:Bothell,_Washington,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
AVI BioPharma
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
eteplirsen
|
| gptkbp:renamed |
gptkb:Sarepta_Therapeutics
|
| gptkbp:tradedOn |
NASDAQ: SRPT
|
| gptkbp:website |
https://www.sarepta.com/
|
| gptkbp:bfsParent |
gptkb:Sarepta_Therapeutics
|
| gptkbp:bfsLayer |
7
|